Article Correctness Is Author's Responsibility: FDA approves Houston Methodist for COVID-19 plasma therapy

The article below may contain offensive and/or incorrect content.

This shows a blood test tube with covid19 written on itOn Saturday, the FDA approved Houston Methodist to conduct transfused plasma therapy for the treatment of COVID-19. The plasma will be donated from recovered COVID-19 patients and transfused into those critically ill with the virus. Researchers have already begun recruiting donors in the Houston area who have recovered from coronavirus. The first donor was a patient in the Houston Metropolitan area who has been in good health for two weeks following COVID-19 infection.